Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study

被引：0
|
作者：
Kurvi Patwala
David Stephen Prince
Yael Celermajer
Waafiqa Alam
Eldho Paul
Simone Irene Strasser
Geoffrey William McCaughan
Paul Gow
Siddharth Sood
Elise Murphy
Stuart Roberts
Elliot Freeman
Elizabeth Stratton
Scott Anthony Davison
Miriam Tania Levy
McCawley Clark-Dickson
Vi Nguyen
Sally Bell
Amanda Nicoll
Ashley Bloom
Alice Unah Lee
Marno Ryan
Jessica Howell
Zina Valaydon
Alexandra Mack
Ken Liu
Anouk Dev
机构：
[1] Monash Health,Department of Gastroenterology
[2] Royal Prince Alfred Hospital,AW Morrow Gastroenterology and Liver Centre
[3] Liverpool Hospital,Department of Gastroenterology
[4] Monash University,Department of Medicine
[5] Austin Health,Department of Gastroenterology and Liver Transplant
[6] Royal Melbourne Hospital,Department of Gastroenterology
[7] Alfred Health,Department of Gastroenterology
[8] Royal North Shore Hospital,Department of Gastroenterology
[9] Eastern Health,Department of Gastroenterology
[10] Concord Repatriation General Hospital,Department of Gastroenterology
[11] St Vincent’s Hospital,Department of Gastroenterology
[12] University of Melbourne,Department of Medicine
[13] Burnet Institute,Disease Elimination Program
[14] Monash University,Department of Epidemiology and Preventative Medicine
[15] Western Health,Department of Gastroenterology
来源：
Hepatology International | 2022年 / 16卷
关键词：
Liver malignancy; Adverse effects; Diarrhoea; Hypertension; Multikinase inhibitor; Chronic liver disease; Systemic therapy; Oral therapy; Australia; Cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1170 / 1178
页数：8
相关论文
共 50 条
  • [1] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    [J]. HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [2] REAL WORLD EVIDENCE OF LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
    Nakano, Masahito
    Kuromatsu, Ryoko
    Niizeki, Takashi
    Okamura, Shusuke
    Iwamoto, Hideki
    Shimose, Shigeo
    Shirono, Tomotake
    Noda, Yu
    Kamachi, Naoki
    Koga, Hironori
    Torimura, Takuji
    [J]. HEPATOLOGY, 2019, 70 : 243A - 244A
  • [3] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    [J]. LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [4] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [5] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
  • [6] Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto., Naoya
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [7] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Ishikawa, Toru
    Kunihiko, Tsuji
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi, Sr.
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    [J]. HEPATOLOGY, 2019, 70 : 217A - 218A
  • [8] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Persano, Mara
    Rimini, Margherita
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Rimassa, Lorenza
    Presa, Jose
    Masi, Gianluca
    Yoo, Changhoon
    Lonardi, Sara
    Tovoli, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Pressiani, Tiziana
    Kawaguchi, Takumi
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Piscaglia, Fabio
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Iavarone, Massimo
    Di Costanzo, Giovanni
    Marra, Fabio
    Scartozzi, Mario
    Tamburini, Emiliano
    Cabibbo, Giuseppe
    Foschi, Francesco Giuseppe
    Silletta, Marianna
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602
  • [9] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    [J]. CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [10] Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
    Ben Khaled, Najib
    Moeller, Marie
    Jochheim, Leonie S.
    Leyh, Catherine
    Ehmer, Ursula
    Boettcher, Katrin
    Pinter, Matthias
    Balcar, Lorenz
    Scheiner, Bernhard
    Weich, Alexander
    Leicht, Hans Benno
    Zarka, Valentina
    Ye, Liangtao
    Schneider, Julia
    Piseddu, Ignazio
    Oecal, Osman
    Rau, Monika
    Sinner, Friedrich
    Venerito, Marino
    Gairing, Simon Johannes
    Foerster, Friedrich
    Mayerle, Julia
    Toni, Enrico N. De
    Geier, Andreas
    Reiter, Florian P.
    [J]. JHEP REPORTS, 2024, 6 (06)
12345